AMICUS THERAPEUTICS, INC. — Director's Dealing 2019

Aug 27, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2019-08-23

Reporting Person: WHITMAN BURKE W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-23	Common Stock	P	4945	$10.07	Acquired	21612	Direct